Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Zeynab Najafova

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4403-5566; OpenAlex author ID A5026778626. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival. Co-author DOI 10.1126/sciadv.aea2106↗
  2. GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair. Co-author DOI 10.1136/gutjnl-2025-336227↗
  3. Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2024-334374↗
  4. Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-328154↗
  5. Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/1541-7786.mcr-22-0916↗
  6. STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-2874↗
  7. Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells. Co-author DOI 10.3390/cancers13133145↗
  8. Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner. Co-author DOI 10.1093/nar/gkx212↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steven A. Johnsen · 8 shared papers, 2017–2026 · strength 1.17
  2. Elisabeth Heßmann · 6 shared papers, 2017–2026 · strength 0.83
  3. Amro M. Abdelrahman · 4 shared papers, 2023–2026 · strength 0.69
  4. Mark Joseph Truty · 4 shared papers, 2023–2026 · strength 0.69
  5. Xin Wang · 4 shared papers, 2021–2025 · strength 0.57
  6. Jochen Gaedcke · 4 shared papers, 2021–2025 · strength 0.57
  7. Ana P. Kutschat · 4 shared papers, 2021–2025 · strength 0.57
  8. Thomas L. Ekstrom · 3 shared papers, 2023–2026 · strength 0.56
  9. Volker Ellenrieder · 3 shared papers, 2021–2026 · strength 0.51
  10. Feda H. Hamdan · 3 shared papers, 2021–2023 · strength 0.38
  11. Jens Thomas Siveke · 3 shared papers, 2017–2023 · strength 0.33
  12. Jennifer A. Yonkus · 2 shared papers, 2023 · strength 0.27
  13. Joana E. Aggrey-Fynn · 2 shared papers, 2023 · strength 0.27
  14. Rondell Patrell Graham · 2 shared papers, 2023 · strength 0.27
  15. Roberto Alva‐Ruiz · 2 shared papers, 2023 · strength 0.27
  16. Stephan A. Hahn · 2 shared papers, 2023 · strength 0.27
  17. Patrick Christian Hermann · 2 shared papers, 2021–2023 · strength 0.23
  18. Shiv K. Singh · 1 shared paper, 2026 · strength 0.20
  19. Muhammad Umair Latif · 1 shared paper, 2026 · strength 0.20
  20. Ulrich Sax · 1 shared paper, 2026 · strength 0.20
  21. Lena‐Christin Conradi · 1 shared paper, 2026 · strength 0.20
  22. Lukas Klein · 1 shared paper, 2026 · strength 0.20
  23. Oliver Holger Krämer · 1 shared paper, 2026 · strength 0.20
  24. Günter Schneider · 1 shared paper, 2026 · strength 0.20
  25. Christina Parassiadis · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.